Annual CFF
-$39.00 M
-$5.30 M-15.73%
December 31, 2023
Summary
- As of February 7, 2025, IOSP annual cash flow from financing activities is -$39.00 million, with the most recent change of -$5.30 million (-15.73%) on December 31, 2023.
- During the last 3 years, IOSP annual CFF has risen by +$47.80 million (+55.07%).
- IOSP annual CFF is now -134.57% below its all-time high of $112.80 million, reached on December 31, 2013.
Performance
IOSP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$900.00 K
+$19.80 M+104.76%
September 30, 2024
Summary
- As of February 7, 2025, IOSP quarterly cash flow from financing activities is $900.00 thousand, with the most recent change of +$19.80 million (+104.76%) on September 30, 2024.
- Over the past year, IOSP quarterly CFF has increased by +$19.80 million (+104.76%).
- IOSP quarterly CFF is now -99.25% below its all-time high of $120.30 million, reached on December 31, 2016.
Performance
IOSP Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$37.90 M
+$700.00 K+1.81%
September 30, 2024
Summary
- As of February 7, 2025, IOSP TTM cash flow from financing activities is -$37.90 million, with the most recent change of +$700.00 thousand (+1.81%) on September 30, 2024.
- Over the past year, IOSP TTM CFF has increased by +$700.00 thousand (+1.81%).
- IOSP TTM CFF is now -133.60% below its all-time high of $112.80 million, reached on December 31, 2013.
Performance
IOSP TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IOSP Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -15.7% | +104.8% | +1.8% |
3 y3 years | +55.1% | 0.0% | -101.6% |
5 y5 years | -7.7% | +107.5% | +56.3% |
IOSP Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -95.0% | at low | at high | +104.4% | -101.6% | +2.8% |
5 y | 5-year | -95.0% | +78.1% | at high | +101.0% | -101.6% | +78.7% |
alltime | all time | -134.6% | +80.1% | -99.3% | +101.0% | -133.6% | +80.7% |
Innospec Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $900.00 K(-104.8%) | -$37.90 M(-1.8%) |
Jun 2024 | - | -$18.90 M(-3880.0%) | -$38.60 M(-0.8%) |
Mar 2024 | - | $500.00 K(-102.5%) | -$38.90 M(-0.3%) |
Dec 2023 | -$39.00 M(+15.7%) | -$20.40 M(<-9900.0%) | -$39.00 M(+9.6%) |
Sep 2023 | - | $200.00 K(-101.0%) | -$35.60 M(-1.7%) |
Jun 2023 | - | -$19.20 M(-4900.0%) | -$36.20 M(+5.8%) |
Mar 2023 | - | $400.00 K(-102.4%) | -$34.20 M(+1.5%) |
Dec 2022 | -$33.70 M(+68.5%) | -$17.00 M(+4150.0%) | -$33.70 M(+43.4%) |
Sep 2022 | - | -$400.00 K(-97.7%) | -$23.50 M(+2.2%) |
Jun 2022 | - | -$17.20 M(-2011.1%) | -$23.00 M(+22.3%) |
Mar 2022 | - | $900.00 K(-113.2%) | -$18.80 M(-6.0%) |
Dec 2021 | -$20.00 M(-77.0%) | -$6.80 M(-6900.0%) | -$20.00 M(-20.6%) |
Sep 2021 | - | $100.00 K(-100.8%) | -$25.20 M(-61.5%) |
Jun 2021 | - | -$13.00 M(+4233.3%) | -$65.50 M(-23.4%) |
Mar 2021 | - | -$300.00 K(-97.5%) | -$85.50 M(-1.5%) |
Dec 2020 | -$86.80 M(-51.2%) | -$12.00 M(-70.1%) | -$86.80 M(-46.1%) |
Sep 2020 | - | -$40.20 M(+21.8%) | -$160.90 M(+7.8%) |
Jun 2020 | - | -$33.00 M(+1962.5%) | -$149.30 M(-16.1%) |
Mar 2020 | - | -$1.60 M(-98.1%) | -$178.00 M(+0.1%) |
Dec 2019 | -$177.90 M(+391.4%) | -$86.10 M(+201.0%) | -$177.90 M(+47.5%) |
Sep 2019 | - | -$28.60 M(-53.6%) | -$120.60 M(+30.8%) |
Jun 2019 | - | -$61.70 M(+4013.3%) | -$92.20 M(+189.0%) |
Mar 2019 | - | -$1.50 M(-94.8%) | -$31.90 M(-11.9%) |
Dec 2018 | -$36.20 M(-45.5%) | -$28.80 M(>+9900.0%) | -$36.20 M(+58.1%) |
Sep 2018 | - | -$200.00 K(-85.7%) | -$22.90 M(-47.1%) |
Jun 2018 | - | -$1.40 M(-75.9%) | -$43.30 M(+3.8%) |
Mar 2018 | - | -$5.80 M(-62.6%) | -$41.70 M(-37.2%) |
Dec 2017 | -$66.40 M(-195.5%) | -$15.50 M(-24.8%) | -$66.40 M(-195.7%) |
Sep 2017 | - | -$20.60 M(<-9900.0%) | $69.40 M(-11.7%) |
Jun 2017 | - | $200.00 K(-100.7%) | $78.60 M(+10.1%) |
Mar 2017 | - | -$30.50 M(-125.4%) | $71.40 M(+2.7%) |
Dec 2016 | $69.50 M(-288.9%) | $120.30 M(-1155.3%) | $69.50 M(-211.7%) |
Sep 2016 | - | -$11.40 M(+62.9%) | -$62.20 M(+5.6%) |
Jun 2016 | - | -$7.00 M(-78.4%) | -$58.90 M(-8.1%) |
Mar 2016 | - | -$32.40 M(+184.2%) | -$64.10 M(+74.2%) |
Dec 2015 | -$36.80 M(+51.4%) | -$11.40 M(+40.7%) | -$36.80 M(+140.5%) |
Sep 2015 | - | -$8.10 M(-33.6%) | -$15.30 M(-42.7%) |
Jun 2015 | - | -$12.20 M(+139.2%) | -$26.70 M(+24.8%) |
Mar 2015 | - | -$5.10 M(-150.5%) | -$21.40 M(-11.9%) |
Dec 2014 | -$24.30 M(-121.5%) | $10.10 M(-151.8%) | -$24.30 M(-317.0%) |
Sep 2014 | - | -$19.50 M(+182.6%) | $11.20 M(-88.2%) |
Jun 2014 | - | -$6.90 M(-13.8%) | $95.30 M(-2.0%) |
Mar 2014 | - | -$8.00 M(-117.5%) | $97.20 M(-13.8%) |
Dec 2013 | $112.80 M(-352.3%) | $45.60 M(-29.4%) | $112.80 M(+563.5%) |
Sep 2013 | - | $64.60 M(-1392.0%) | $17.00 M(-135.3%) |
Jun 2013 | - | -$5.00 M(-165.8%) | -$48.20 M(+26.5%) |
Mar 2013 | - | $7.60 M(-115.1%) | -$38.10 M(-14.8%) |
Dec 2012 | -$44.70 M(-18.7%) | -$50.20 M(+8266.7%) | -$44.70 M(-25.4%) |
Sep 2012 | - | -$600.00 K(-111.8%) | -$59.90 M(+83.2%) |
Jun 2012 | - | $5.10 M(+410.0%) | -$32.70 M(+3.2%) |
Mar 2012 | - | $1.00 M(-101.5%) | -$31.70 M(-42.4%) |
Dec 2011 | -$55.00 M | -$65.40 M(-345.9%) | -$55.00 M(-885.7%) |
Sep 2011 | - | $26.60 M(+336.1%) | $7.00 M(-137.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2011 | - | $6.10 M(-127.4%) | -$18.60 M(-18.1%) |
Mar 2011 | - | -$22.30 M(+555.9%) | -$22.70 M(+249.2%) |
Dec 2010 | -$6.50 M(-75.6%) | -$3.40 M(-440.0%) | -$6.50 M(-50.8%) |
Sep 2010 | - | $1.00 M(-50.0%) | -$13.20 M(-30.5%) |
Jun 2010 | - | $2.00 M(-132.8%) | -$19.00 M(-34.7%) |
Mar 2010 | - | -$6.10 M(-39.6%) | -$29.10 M(+9.4%) |
Dec 2009 | -$26.60 M(+56.5%) | -$10.10 M(+110.4%) | -$26.60 M(-29.3%) |
Sep 2009 | - | -$4.80 M(-40.7%) | -$37.60 M(+79.9%) |
Jun 2009 | - | -$8.10 M(+125.0%) | -$20.90 M(-367.9%) |
Mar 2009 | - | -$3.60 M(-82.9%) | $7.80 M(-145.9%) |
Dec 2008 | -$17.00 M(-80.0%) | -$21.10 M(-277.3%) | -$17.00 M(-20.2%) |
Sep 2008 | - | $11.90 M(-42.2%) | -$21.30 M(-62.5%) |
Jun 2008 | - | $20.60 M(-172.5%) | -$56.80 M(+49.1%) |
Mar 2008 | - | -$28.40 M(+11.8%) | -$38.10 M(-55.2%) |
Dec 2007 | -$85.10 M(+1050.0%) | -$25.40 M(+7.6%) | -$85.10 M(+40.9%) |
Sep 2007 | - | -$23.60 M(-160.1%) | -$60.40 M(+54.9%) |
Jun 2007 | - | $39.30 M(-152.1%) | -$39.00 M(-53.0%) |
Mar 2007 | - | -$75.40 M(>+9900.0%) | -$83.00 M(+1021.6%) |
Dec 2006 | -$7.40 M(-147.7%) | -$700.00 K(-68.2%) | -$7.40 M(-75.4%) |
Sep 2006 | - | -$2.20 M(-53.2%) | -$30.10 M(+246.0%) |
Jun 2006 | - | -$4.70 M(-2450.0%) | -$8.70 M(+38.1%) |
Mar 2006 | - | $200.00 K(-100.9%) | -$6.30 M(-140.6%) |
Dec 2005 | $15.50 M(+86.7%) | -$23.40 M(-221.9%) | $15.50 M(+56.6%) |
Sep 2005 | - | $19.20 M(-934.8%) | $9.90 M(-61.5%) |
Jun 2005 | - | -$2.30 M(-110.5%) | $25.70 M(-4.1%) |
Mar 2005 | - | $22.00 M(-175.9%) | $26.80 M(+222.9%) |
Dec 2004 | $8.30 M(-115.6%) | -$29.00 M(-182.9%) | $8.30 M(-27.2%) |
Sep 2004 | - | $35.00 M(-3016.7%) | $11.40 M(-125.1%) |
Jun 2004 | - | -$1.20 M(-134.3%) | -$45.40 M(-4.8%) |
Mar 2004 | - | $3.50 M(-113.5%) | -$47.70 M(-10.3%) |
Dec 2003 | -$53.20 M(-28.1%) | -$25.90 M(+18.8%) | -$53.20 M(+38.5%) |
Sep 2003 | - | -$21.80 M(+522.9%) | -$38.40 M(+42.2%) |
Jun 2003 | - | -$3.50 M(+75.0%) | -$27.00 M(-20.1%) |
Mar 2003 | - | -$2.00 M(-82.0%) | -$33.80 M(-54.3%) |
Dec 2002 | -$74.00 M(>+9900.0%) | -$11.10 M(+6.7%) | -$74.00 M(+25.0%) |
Sep 2002 | - | -$10.40 M(+1.0%) | -$59.20 M(+33.0%) |
Jun 2002 | - | -$10.30 M(-75.6%) | -$44.50 M(+3.5%) |
Mar 2002 | - | -$42.20 M(-1240.5%) | -$43.00 M(+7066.7%) |
Dec 2001 | -$600.00 K(-99.5%) | $3.70 M(-14.0%) | -$600.00 K(-97.5%) |
Sep 2001 | - | $4.30 M(-148.9%) | -$24.20 M(-55.1%) |
Jun 2001 | - | -$8.80 M(-4500.0%) | -$53.90 M(-39.1%) |
Mar 2001 | - | $200.00 K(-101.0%) | -$88.50 M(-23.0%) |
Dec 2000 | -$114.90 M(+42.2%) | -$19.90 M(-21.7%) | -$114.90 M(-11.3%) |
Sep 2000 | - | -$25.40 M(-41.5%) | -$129.50 M(+9.2%) |
Jun 2000 | - | -$43.40 M(+65.6%) | -$118.60 M(+20.2%) |
Mar 2000 | - | -$26.20 M(-24.1%) | -$98.70 M(+22.2%) |
Dec 1999 | -$80.80 M(-58.8%) | -$34.50 M(+137.9%) | -$80.80 M(-14.9%) |
Sep 1999 | - | -$14.50 M(-38.3%) | -$95.00 M(-31.4%) |
Jun 1999 | - | -$23.50 M(+183.1%) | -$138.40 M(-18.7%) |
Mar 1999 | - | -$8.30 M(-83.0%) | -$170.20 M(-13.2%) |
Dec 1998 | -$196.10 M | -$48.70 M(-15.9%) | -$196.10 M(+33.0%) |
Sep 1998 | - | -$57.90 M(+4.7%) | -$147.40 M(+64.7%) |
Jun 1998 | - | -$55.30 M(+61.7%) | -$89.50 M(+161.7%) |
Mar 1998 | - | -$34.20 M | -$34.20 M |
FAQ
- What is Innospec annual cash flow from financing activities?
- What is the all time high annual CFF for Innospec?
- What is Innospec annual CFF year-on-year change?
- What is Innospec quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Innospec?
- What is Innospec quarterly CFF year-on-year change?
- What is Innospec TTM cash flow from financing activities?
- What is the all time high TTM CFF for Innospec?
- What is Innospec TTM CFF year-on-year change?
What is Innospec annual cash flow from financing activities?
The current annual CFF of IOSP is -$39.00 M
What is the all time high annual CFF for Innospec?
Innospec all-time high annual cash flow from financing activities is $112.80 M
What is Innospec annual CFF year-on-year change?
Over the past year, IOSP annual cash flow from financing activities has changed by -$5.30 M (-15.73%)
What is Innospec quarterly cash flow from financing activities?
The current quarterly CFF of IOSP is $900.00 K
What is the all time high quarterly CFF for Innospec?
Innospec all-time high quarterly cash flow from financing activities is $120.30 M
What is Innospec quarterly CFF year-on-year change?
Over the past year, IOSP quarterly cash flow from financing activities has changed by +$19.80 M (+104.76%)
What is Innospec TTM cash flow from financing activities?
The current TTM CFF of IOSP is -$37.90 M
What is the all time high TTM CFF for Innospec?
Innospec all-time high TTM cash flow from financing activities is $112.80 M
What is Innospec TTM CFF year-on-year change?
Over the past year, IOSP TTM cash flow from financing activities has changed by +$700.00 K (+1.81%)